當(dāng)前位置：臺州市科瑞生物技術(shù)有限公司>>其他>>阿尼芬凈

阿尼芬凈

返回列表頁

參考價

面議

具體成交價以合同協(xié)議為準(zhǔn)

產(chǎn)品型號cas 166663-25-8

品牌其他品牌

廠商性質(zhì)生產(chǎn)商

所在地臺州市

在線詢價收藏產(chǎn)品

聯(lián)系方式：金崇光查看聯(lián)系方式

更新時間：2020-09-03 15:35:50瀏覽次數(shù)：277次

聯(lián)系我時，請告知來自制藥網(wǎng)

產(chǎn)品分類 品牌分類

  前列腺素系列
  獸藥原料藥
  其他

  其他品牌

臺州市科瑞生物技術(shù)有限公司

經(jīng)營模式：生產(chǎn)廠家

商鋪產(chǎn)品：182條

所在地區(qū)：浙江臺州市

聯(lián)系人：金崇光（總經(jīng)理）

詢價 給他留言

產(chǎn)品簡介

CAS號	166663-25-8	產(chǎn)地	國產(chǎn)
分子式	C58H73N7O17	級別	醫(yī)用級

阿尼芬凈Anidulafungin （LY303366）, 一種echinocandin的衍生物, 抑制glucan synthase的活性, 用作抗真菌藥。

詳細(xì)介紹

阿尼芬凈Anidulafungin (LY303366), 一種echinocandin的衍生物, 抑制glucan synthase的活性, 用作抗真菌藥。

物化屬性:

密度：1.47

沸點(diǎn)：1477°Cat760mmHg

折射率：1.688

閃光點(diǎn)：847°C

PSA：377.42000

LOGP：0.65480

Anidulafungin (LY-303366) has MICs of ≤0.32 μg/mL for all Candida albicans (n=99), Candida glabrata (n=18), and Candida tropicalis (n=10) isolates tested. Anidulafungin is also active against Aspergillus species (minimum effective concentration at which 90% of the isolates are inhibited, 0.02 μg/mL) (n=20), is less active against Candida parapsilosis (MIC at which 90% of the isolates are inhibited [MIC90], 5.12 μg/mL) (n=10), and is inactive against C. neoformans (MIC90 >10.24 μg/mL) (n=15) and B. dermatitidis (MIC90, 16 μg/mL) (n=29).The MICs of Fluconazole for three strains of C. tropicalis, seven strains of C. glabrata, and two strains of Candida krusei are ≥16 μg/mL. The MICs of Anidulafungin for 11 of these 12 strains range from 0.08 to 0.32 mg/mL. The twelfth strain is a C. krusei strain (Fluconazole MIC, 32 μg/mL) for which the Anidulafungin MIC is 1.28 mg/mL. The MIC at which 90% of the isolates are inhibited (MIC90) for these 12 strains is 0.32 μg/mL. The Anidulafungin MIC90 for the remaining 18 C. glabrata isolates and C. tropicalis isolates for which the Fluconazole MICs are ≥ 8 μg/mL is also 0.32 mg/mL. Anidulafungin appeares equally active against Candida species for which the fluconazole MICs are ≥16 mg/mL and against those for which the fluconazole MICs are ≥ 8 μg/mL. Anidulafungin has significantly less activity against C. neoformans and B. dermatitidis than against C. albicans, C. glabrata, and C. tropicalis. Ketoconazole and amphotericin B are the most active antifungal agents tested for both C. neoformans and B. dermatitidis. Anidulafungin demonstrated potent in vitro activity against Aspergillus species with a MEC90 of 0.02 μg/mL. MICs of Anidulafungin for the control strain yeast isolates are 0.02 μg/mL for C. albicans ATCC 90028, 0.16 mg/mL for C. glabrata ATCC 90030, and >10.24 μg/mL for C. neoformans ATCC 90112^[1]. Strains selected with CD101 that have a 2-fold or greater CD101 MIC increase also have at least a 2-fold MIC increase for Anidulafungin (ANF) and/or Caspofungin (CSF)^[2].